Trimas (TRS)
NASDAQ:TRS
Want to see TRS full AI Analyst Report?
TRS Stock Chart & Stats
$38.24
$0.15(0.66%)
At close: 4:00 PM EST
$38.24
$0.15(0.66%)
Day’s Range― - ―
52-Week Range$25.58 - $43.72
Previous CloseN/A
Volume59.55K
Average Volume (3M)486.97K
Market Cap
$1.44B
Enterprise Value$596.10M
Total Cash (Recent Filing)$1.31B
Total Debt (Recent Filing)$439.28M
Price to Earnings (P/E)1.7
Beta0.85
Next Earnings
Jul 23, 2026EPS Estimate
0.49Next Dividend Ex-DateN/A
Dividend Yield0.45%
Share Statistics
EPS (TTM)24.10
Shares Outstanding35,827,686
10 Day Avg. Volume405,984
30 Day Avg. Volume486,969
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)2.03
Price to Sales (P/S)2.22
P/FCF Ratio20.72
Enterprise Value/Market Cap0.41
Enterprise Value/Revenue0.69
Enterprise Value/Gross Profit3.04
Enterprise Value/Ebitda5.15
Forecast
1Y Price Target
$45.00Price Target Upside17.68% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)1.57
Revenue Forecast (FY)$679.48M
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthThe $1.4B gross divestiture transformed TriMas into a net cash company with debt-to-equity ~0.03, materially increasing financial flexibility. This durable capital base lowers interest risk, supports sustained buybacks, opportunistic M&A or capex, and insulates operations through downturns.
Reaffirmed 2026 Guidance & Margin ExpansionManagement’s reaffirmed outlook calls for >300bps margin improvement and significant EPS upside, driven by cost actions and structural margin programs. If delivered, this provides a sustainable profitability uplift, improving cash generation and strategic optionality over the next 2–6 months and beyond.
End‑Market Momentum In Packaging & SpecialtyStrong organic demand in beauty/personal care, life sciences and specialty (Norris) indicates durable end-market exposure and product differentiation. Broad-based segment growth suggests improving mix toward higher-value engineered solutions, supporting sustainable top-line recovery and margin resilience.
Bears Say
Declining TTM RevenueA persistent revenue decline weakens operating leverage and puts pressure on sustainable earnings. Even with margin initiatives, durable value creation requires consistent organic revenue recovery; continued top-line volatility raises execution risk and may constrain long-term margin scalability.
Weak Cash Conversion And FCF MomentumEarnings have not translated proportionally into cash: FCF fell ~30% and cash conversion lags net income. Persistent weak cash generation can limit sustainable capex, dividends or M&A despite a strong balance sheet, and signals potential fragility in earnings quality over the medium term.
Earnings Quality Distortion From One‑offsExtremely elevated net margin driven by one-time items distorts profitability metrics. Reliance on nonrecurring gains reduces predictability of future EPS and can mislead resource allocation; durable assessment should focus on underlying EBITDA and recurring cash flow trends instead.
Trimas News
TRS FAQ
What was Trimas’s price range in the past 12 months?
Trimas lowest stock price was $25.58 and its highest was $43.72 in the past 12 months.
What is Trimas’s market cap?
Trimas’s market cap is $1.44B.
When is Trimas’s upcoming earnings report date?
Trimas’s upcoming earnings report date is Jul 23, 2026 which is in 49 days.
How were Trimas’s earnings last quarter?
Trimas released its earnings results on Apr 30, 2026. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.05.
Is Trimas overvalued?
According to Wall Street analysts Trimas’s price is currently Undervalued.
Does Trimas pay dividends?
Trimas pays a Quarterly dividend of $0.04 which represents an annual dividend yield of 0.45%. See more information on Trimas dividends here
What is Trimas’s EPS estimate?
Trimas’s EPS estimate is 0.49.
How many shares outstanding does Trimas have?
Trimas has 35,827,686 shares outstanding.
What happened to Trimas’s price movement after its last earnings report?
Trimas reported an EPS of $0.24 in its last earnings report, beating expectations of $0.19. Following the earnings report the stock price went up 2.605%.
Which hedge fund is a major shareholder of Trimas?
Currently, no hedge funds are holding shares in TRS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Trimas Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$45.00 (17.68% Upside)
$45.00 (17.68% Upside)
Blogger Sentiment
Bullish
TRS Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 693.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $201.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 2.4%
Last 30 Days ▼ 2.4%
Technicals
SMA
Positive
20 days / 200 days
Momentum
55.54%
12-Months-Change
Fundamentals
Return on Equity
101.07%
Trailing 12-Months
Asset Growth
64.82%
Trailing 12-Months
Company Description
Trimas
TriMas Corporation designs, develops, manufactures, and sells products for consumer products, aerospace, and industrial markets worldwide. It operates through three segments: Packaging, Aerospace, and Specialty Products. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, flexible spouts, and agricultural closures; polymeric jar products; integrated dispensers; bag-in-box products; aseptic closures; industrial closures and flex spouts; custom injection molded components and devices; various injection molded products; and single-bodied and assembled caps and closures under the Rieke, Taplast, Affaba & Ferrari, Stolz, Omega, and Rapak brands. The Aerospace segment provides fasteners, collars, blind bolts, rivets, ducting, and connectors for air management systems, and machined parts and components to original equipment manufacturers, supply chain distributors, MRO/aftermarket providers, and tier one suppliers; and military and defense aerospace applications and platforms under the Monogram Aerospace Fasteners, Allfast Fastening Systems, Mac Fasteners, TFI Aerospace, RSA Engineered Products, and Martinic Engineering brands. The Specialty Products segment offers steel cylinders for use in the transportation, storage, and dispensing of compressed gases under the Norris Cylinder brand; natural gas powered wellhead engines, compressors, and replacement parts for oil and natural gas production, and other industrial and commercial markets under the Arrow brand; and spare parts for various industrial engines. The company sells its products through a direct sales force, third-party agents, and distributors. TriMas Corporation was incorporated in 1986 and is headquartered in Bloomfield Hills, Michigan.
TRS Company Deck
TRS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a largely positive outlook driven by a transformative aerospace divestiture, a strengthened balance sheet (net cash $913M), double-digit sales growth in Q1 (>10%), margin expansion (120 bps), significant EPS upside with 2026 guidance of $1.50–$1.70 (≈191% improvement at midpoint), and concrete cost-savings actions expected to deliver $10M in 2026 and >$15M annually. Near-term headwinds include a one-time low-margin tooling sale that pressured Packaging mix, potential timing lag in commodity pass-through (possible Q2 margin pressure), seasonal Q1 cash usage (-$16M FCF), upcoming tax payments (~$200M), and monitored geopolitical/supply chain risks. Overall, the positive financial progress and strategic capital position meaningfully outweigh the manageable near-term challenges.View all TRS earnings summariesTRS Stock 12 Month Forecast
Average Price Target
$45.00
▲(17.68% Upside)
Technical Analysis
Ownership Overview
18.54% Insiders
30.46% Mutual Funds
18.64% Other Institutional Investors
12.59% Public Companies and
Individual Investors